Pharmaceutical

NVIDIA invests $50m in AI-enabled drug discovery

NVIDIA signed an investment and collaboration agreement with Recursion to create AI models to accelerate drug discovery.

Jul 13, 2023 - 20:00
NVIDIA invests $50m in AI-enabled drug discovery
NVIDIA signed an investment and collaboration agreement with Recursion to create AI models to accelerate drug discovery.
Read the original article

Tags:

Previous Article

Actimed plans trials to treat muscle wasting syndrome in cancer patients

Next Article

Aridis’s AR-301 monoclonal antibody to receive FDA QIDP designation

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Apellis safety probe of eye disease drug identifies injection needle as possible cause of severe side effect

STAT+: Apellis safety probe of eye disease drug identif...

Aug 23, 2023

STAT+: House transparency, PBM reform bill gains bipartisan support

STAT+: House transparency, PBM reform bill gains bipart...

Sep 8, 2023

Novartis acquires Kate Therapeutics to advance gene therapies

Novartis acquires Kate Therapeutics to advance gene the...

Nov 23, 2024